117 related articles for article (PubMed ID: 9459017)
1. Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy.
Gonnella NC; Li YC; Zhang X; Paris CG
Bioorg Med Chem; 1997 Dec; 5(12):2193-201. PubMed ID: 9459017
[TBL] [Abstract][Full Text] [Related]
2. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Skotnicki JS; Wilhelm J; Powers R
Biochemistry; 1999 Jun; 38(22):7085-96. PubMed ID: 10353819
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
Li YC; Zhang X; Melton R; Ganu V; Gonnella NC
Biochemistry; 1998 Oct; 37(40):14048-56. PubMed ID: 9760240
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
[TBL] [Abstract][Full Text] [Related]
5. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.
Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R
Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871
[TBL] [Abstract][Full Text] [Related]
7. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360
[TBL] [Abstract][Full Text] [Related]
8. Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects.
Gonnella NC; Bohacek R; Zhang X; Kolossváry I; Paris CG; Melton R; Winter C; Hu SI; Ganu V
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):462-6. PubMed ID: 7831311
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry.
Parker MH; Lunney EA; Ortwine DF; Pavlovsky AG; Humblet C; Brouillette CG
Biochemistry; 1999 Oct; 38(41):13592-601. PubMed ID: 10521266
[TBL] [Abstract][Full Text] [Related]
10. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
Pavlovsky AG; Williams MG; Ye QZ; Ortwine DF; Purchase CF; White AD; Dhanaraj V; Roth BD; Johnson LL; Hupe D; Humblet C; Blundell TL
Protein Sci; 1999 Jul; 8(7):1455-62. PubMed ID: 10422833
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography.
Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Axel MG; Caldwell CG; Hagmann WK; Becker JW
J Biomol NMR; 1996 Jan; 7(1):8-28. PubMed ID: 8720828
[TBL] [Abstract][Full Text] [Related]
15. The NMR structure of the inhibited catalytic domain of human stromelysin-1.
Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Salowe SP; Bush BL; Hermes JD; Esser CK; Hagmann WK; Springer JP
Nat Struct Biol; 1994 Feb; 1(2):111-8. PubMed ID: 7656014
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.
Yuan P; Marshall VP; Petzold GL; Poorman RA; Stockman BJ
J Biomol NMR; 1999 Sep; 15(1):55-64. PubMed ID: 10549133
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective binding of an enantiomeric pair of stromelysin-1 inhibitors caused by conformational entropy factors.
Parker MH; Ortwine DF; O'Brien PM; Lunney EA; Banotai CA; Mueller WT; McConnell P; Brouillette CG
Bioorg Med Chem Lett; 2000 Nov; 10(21):2427-30. PubMed ID: 11078193
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
